Table 4.
Number of patients | Prostate with rectal spacer (n = 23) | Prostate without rectal spacer (n = 10) | Prostate bed (n = 9) | Total (n = 42) |
Follow up duration | ||||
Median[range] | 21 [3;31] | 18 [4;28] | 17 [3;20] | 21 [3;31] |
PFS | ||||
Median [range] (months) | 10 [3 ; 21] | 9 [4 ; 20] | 11 [3 ; 17] | 11 [3 ; 21] |
Site of progression | ||||
In field | 0 | 0 | 0 | 0 |
Out field | 4 | 2 | 1 | 7 (17%) |
-Bones | 1 | 0 | 0 | 1 (2%) |
-Lymph nodes | 3 | 1 | 1 | 5 (12%) |
-Bones and lymph nodes | 1 | 0 | 0 | 1 (2%) |
Biochemical only | 0 | 0 | 1 | 1 (2%) |